Literature DB >> 2169081

Percutaneous alcohol injection of portal thrombosis in hepatocellular carcinoma: a new possible treatment.

T Livraghi1, W Grigioni, A Mazziotti, G Sangalli, C Vettori.   

Abstract

Hepatocellular carcinoma (HCC) with portal thrombosis is usually regarded as a contraindication for surgery and for percutaneous alcohol injection (PAI). For palliative purposes we used PAI in 4 patients with infiltrative HCC and segmental portal thrombosis. Ethanol, injected directly into the thrombus, diffused mostly along it. No complications emerged after 20 injections. In the first patient, who later received a liver transplant, the thrombus was completely necrotic. In the other patients, biopsies yielded only necrotic material: in two cases, progression of the thrombus was stopped at 4 and 12 months of follow-up, and in one case the thrombus shrank and remained as such 13 months later. This preliminary experience might broaden the scope of treatment for HCC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169081     DOI: 10.1177/030089169007600418

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

1.  Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein.

Authors:  J Fan; Z Q Wu; Z Y Tang; J Zhou; S J Qiu; Z C Ma; X D Zhou; S L Ye
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes.

Authors:  Xiao-Ping Chen; Zhi-Yong Huang
Journal:  Langenbecks Arch Surg       Date:  2005-05-04       Impact factor: 3.445

3.  Radiofrequency ablation of hepatocellular carcinoma extended into the portal vein: Preliminary results.

Authors:  A Giorgio; G de Stefano; A Di Sarno; N Farella; V Giorgio; U Scognamiglio; A Mariniello; G Liorre; A Perrotta; N Mariniello
Journal:  J Ultrasound       Date:  2009-01-20

4.  Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study.

Authors:  Luciano Tarantino; Giuseppina Busto; Aurelio Nasto; Raffaele Fristachi; Luigi Cacace; Maria Talamo; Catello Accardo; Sara Bortone; Paolo Gallo; Paolo Tarantino; Riccardo Aurelio Nasto; Matteo Nicola Dario Di Minno; Pasquale Ambrosino
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

Review 5.  Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers.

Authors:  Lucia Cerrito; Brigida Eleonora Annicchiarico; Roberto Iezzi; Antonio Gasbarrini; Maurizio Pompili; Francesca Romana Ponziani
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.